ES2071786T3 - Compuestos bloqueadores de nmda, composiciones farmaceuticas, su preparacion y su uso. - Google Patents
Compuestos bloqueadores de nmda, composiciones farmaceuticas, su preparacion y su uso.Info
- Publication number
- ES2071786T3 ES2071786T3 ES90312147T ES90312147T ES2071786T3 ES 2071786 T3 ES2071786 T3 ES 2071786T3 ES 90312147 T ES90312147 T ES 90312147T ES 90312147 T ES90312147 T ES 90312147T ES 2071786 T3 ES2071786 T3 ES 2071786T3
- Authority
- ES
- Spain
- Prior art keywords
- designates
- preparation
- chained
- straight
- pharmaceutical compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA UTILIZACION DEL COMPUESTO DE LA FORMULA: CON LA CONFIGURACION DE (3S, 4S) Y LIBRE ESENCIALMENTE DEL ENANTIOMERO (3R, 4R), DONDE A---B DESIGNAN UNA DOBLE UNION 1(2) O 6(1), R DESIGNA -CH SUB 3 O -CH SUB 2 OH, R ELEVADO 1 DESIGNA UN ATOMO DE HIDROGENO O UN GRUPO DE BAJO ACIL, Y R (AL CUADRADO) DESIGNA (A) UN RADICAL ALCALINO DE CADENA DIRECTA O RAMIFICADA C SUB 6-12; O (B) UN GRUPO RADICAL ALCALINO C SUB 5-9 DE CADENA DIRECTA O RAMIFICADA O UN RADICAL SUSTITUIDO EN EL ATOMO DE CARBONO TERMINAL POR UN GRUPO DE FENILO EN LA FABRICACION DE UN MEDICAMENTO PARA REDUCIR O PREVENIR LA NEUROTOXICIDAD GLUTAMATICA. ALGUNOS DE LOS COMPUESTOS ANTERIORES SON NUEVOS Y SE DESCRIBE SU PREPARACION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL9223889A IL92238A (en) | 1989-11-07 | 1989-11-07 | ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2071786T3 true ES2071786T3 (es) | 1995-07-01 |
Family
ID=11060554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90312147T Expired - Lifetime ES2071786T3 (es) | 1989-11-07 | 1990-11-06 | Compuestos bloqueadores de nmda, composiciones farmaceuticas, su preparacion y su uso. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0427518B1 (es) |
JP (1) | JPH0768235B2 (es) |
KR (1) | KR950005914B1 (es) |
AT (1) | ATE119898T1 (es) |
AU (1) | AU631262B2 (es) |
CA (1) | CA2029419C (es) |
DE (1) | DE69017839T2 (es) |
DK (1) | DK0427518T3 (es) |
ES (1) | ES2071786T3 (es) |
IL (1) | IL92238A (es) |
ZA (1) | ZA908914B (es) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
US6413948B1 (en) | 1996-09-27 | 2002-07-02 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of effecting a neuronal activity in an animal using naaladase inhibitors |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19706903A1 (de) | 1997-02-21 | 1998-08-27 | Bayer Ag | Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1 |
AU743788B2 (en) * | 1997-05-07 | 2002-02-07 | Unimed Pharmaceuticals, Inc. | Method of improving disturbed behavior and elevating mood in humans |
ATE367809T1 (de) | 1998-04-21 | 2007-08-15 | Us Health | Cannabinoiden als antioxidantien und neuroschützende mittel |
ZA200802767B (en) | 2005-09-29 | 2009-09-30 | Amr Technology Inc | Process for production of delta-9-tetrahydrocannabinol |
DE102015112092B4 (de) | 2015-07-24 | 2022-03-10 | Beko Technologies Gmbh | Öl/Wasser-Trennvorrichtung mit Druckluftbeaufschlagung |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL48824A (en) * | 1976-01-12 | 1980-05-30 | Yissum Res Dev Co | Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type |
US4133819A (en) * | 1977-06-17 | 1979-01-09 | Pfizer Inc. | Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents |
US4209520A (en) * | 1977-06-17 | 1980-06-24 | Pfizer Inc. | Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents |
IL80411A (en) * | 1986-10-24 | 1991-08-16 | Raphael Mechoulam | Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them |
-
1989
- 1989-11-07 IL IL9223889A patent/IL92238A/en not_active IP Right Cessation
-
1990
- 1990-11-06 DE DE69017839T patent/DE69017839T2/de not_active Expired - Fee Related
- 1990-11-06 EP EP90312147A patent/EP0427518B1/en not_active Expired - Lifetime
- 1990-11-06 AU AU65834/90A patent/AU631262B2/en not_active Ceased
- 1990-11-06 ES ES90312147T patent/ES2071786T3/es not_active Expired - Lifetime
- 1990-11-06 DK DK90312147.3T patent/DK0427518T3/da active
- 1990-11-06 AT AT90312147T patent/ATE119898T1/de not_active IP Right Cessation
- 1990-11-07 CA CA002029419A patent/CA2029419C/en not_active Expired - Fee Related
- 1990-11-07 KR KR1019900018114A patent/KR950005914B1/ko not_active IP Right Cessation
- 1990-11-07 JP JP2302296A patent/JPH0768235B2/ja not_active Expired - Fee Related
- 1990-11-07 ZA ZA908914A patent/ZA908914B/xx unknown
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
US5985855A (en) | 1996-09-27 | 1999-11-16 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using NAALADase inhibitors |
US6004946A (en) | 1996-09-27 | 1999-12-21 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
US6413948B1 (en) | 1996-09-27 | 2002-07-02 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of effecting a neuronal activity in an animal using naaladase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
IL92238A (en) | 1995-07-31 |
CA2029419A1 (en) | 1991-05-08 |
EP0427518B1 (en) | 1995-03-15 |
IL92238A0 (es) | 1990-07-26 |
EP0427518A1 (en) | 1991-05-15 |
AU631262B2 (en) | 1992-11-19 |
KR950005914B1 (ko) | 1995-06-07 |
CA2029419C (en) | 2004-05-25 |
DE69017839T2 (de) | 1995-08-31 |
ZA908914B (en) | 1991-09-25 |
JPH0768235B2 (ja) | 1995-07-26 |
ATE119898T1 (de) | 1995-04-15 |
DE69017839D1 (de) | 1995-04-20 |
KR910009687A (ko) | 1991-06-28 |
JPH03209377A (ja) | 1991-09-12 |
AU6583490A (en) | 1991-05-30 |
DK0427518T3 (da) | 1995-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ240230A (en) | Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof | |
PH24503A (en) | New pharmaceutical compositions having psychotropic activity | |
FR2694004B1 (fr) | Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent. | |
IL105827A0 (en) | Thienobenzodiazepines,their preparation and pharmaceutical compositions containing them | |
TW340115B (en) | Triazine derivatives and pharmaceutical composition for hepatitis the invention relates to triazine derivatives and pharmaceutical composition for hepatitis | |
IT1228288B (it) | Composti ad attivita' antiserotoninica | |
ES2071786T3 (es) | Compuestos bloqueadores de nmda, composiciones farmaceuticas, su preparacion y su uso. | |
ES2046641T3 (es) | Composicion antitumoral. | |
IL113837A0 (en) | [(3,4-difluorophenoxy)methyl] oxirane and its preparation | |
FI911138A (fi) | Ny substituerad aminfoerening och foerfarande foer dess framstaellning. | |
GR3017348T3 (en) | Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same. | |
IL95762A0 (en) | Benzanilides,their preparation and pharmaceutical compositions containing the same | |
ATE92315T1 (de) | Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate. | |
MX9206930A (es) | Nuevos compuestos | |
DE69001004D1 (de) | Zusammensetzung gegen leberkrankheiten. | |
NZ227682A (en) | Thioformamide derivatives, preparation thereof and pharmaceutical compositions | |
ES2062214T3 (es) | Derivados de aminooligohidroxi inhibidores de renina. | |
GR3007498T3 (es) | ||
ATE29133T1 (de) | Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
GR3021200T3 (en) | (Cyclohexyl)-alken compounds, process for their preparation and pharmaceutical compositions containing them. | |
EP0826663A3 (en) | Alkynylamino acid derivatives and their use as pharmaceutical compounds | |
ATE87004T1 (de) | Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 427518 Country of ref document: ES |